0      0

W001 - Welcome and Introduction

‐ Oct 21, 2020 8:15am

Faced with the explosive outbreak of COVID-19 across the globe, the biopharmaceutical industry is working with academic institutions and health authorities to develop new therapeutic products and preventive medicines. In this half-day virtual discussion forum, we will look at several ongoing studies on the strategies and progress of product and process development- all within accelerated timeline. Researchers and regulators have taken on this unprecedented challenge with innovative technologies, acceleration and risk-based control strategies. With the sharing of demonstrated ability to shorten development timelines required to bring forward treatment options desperately needed to save lives in this pandemic, we aspire to identify new ideas, effective strategies, and efficient CMC (Chemistry, Manufacturing and Control) practices that can lead to faster development of many other important medicines.


You must be logged in and own this session in order to post comments.